Daxor Corporation - Closed End Fund (DXR) earnings
Quarterly and annual DXR reports and results, each read against the price at its own news timestamp. Back to the DXR overview →
No DXR earnings events in the measured window.
Nothing matched in the current window — the DXR overview has every event we measure for this name.
Get an email when DXR moves on news →Keep exploring
More DXR: analyst actions → · SEC filings → · DXR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| InfuSystems Holdings, Inc. (INFU) | 202 | 0.00% | 50% |
| Regulus Therapeutics Inc. (RGLS) | 201 | +0.26% | 55% |
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
| ProPhase Labs, Inc. (PRPH) | 198 | -0.18% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.